Showing results (381-390 of 436) with videos related to
Sort By:
Pageof 44
Biomed Research International|December 22, 2016
Portal Vein Stenting Combined with Iodine-125 Seeds Endovascular Implantation Followed by Transcatheter Arterial Chemoembolization for Treatment of Hepatocellular Carcinoma Patients with Portal Vein Tumor ThrombusJun-Hui Sun, Tanyang Zhou, Tongyin Zhu, et al.Proteomics|February 27, 2010
The impact of miR-34a on protein output in hepatocellular carcinoma HepG2 cellsJun Cheng, Lin Zhou, Qin-Fen Xie, et al.American Journal of Translational Research|September 10, 2019
Dimethyl fumarate suppresses hepatocellular carcinoma progression via activating SOCS3/JAK1/STAT3 signaling pathwayHua Liu, Xiao-De Feng, Beng Yang, et al.Hepatobiliary & Pancreatic Diseases International : HBPD INT|June 6, 2007
No association exists between E-cadherin gene polymorphism and tumor recurrence in patients with hepatocellular carcinoma after transplantationXiao-Dong Li, Li-Ming Wu, Hai-Yang Xie, et al.Transplant International : Official Journal of the European Society for Organ Transplantation|June 4, 2009
Mycophenolate mofetil attenuates liver ischemia/reperfusion injury in ratsYuan-Xing Liu, Li-Ming Jin, Lin Zhou, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 3, 2014
First case report of isolated penile mucormycosis in a liver transplantation recipientMing-chun Lai, Wei Zhang, Zhe Yang, et al.Hepatobiliary & Pancreatic Diseases International : HBPD INT|November 3, 2022
A mixed blessing for liver transplantation patients - RapamycinGuang-Han Fan, Chen-Zhi Zhang, Feng-Qiang Gao, et al.Hepatobiliary & Pancreatic Diseases International : HBPD INT|July 23, 2025
circ0006646 serves as a robust prognostic biomarker for post-transplant tumor recurrence and survival in hepatocellular carcinoma patientsRong-Gao Chen, Guan-Rong Chen, Xiao-Xiao Jiang, et al.Journal of Cancer|March 5, 2020
Macrovascular Endothelial Cells Enhance the Motility of Liver Cancer Cells by Up-regulation of MMP-3, Activation of Integrin/FAK Signaling Pathway and Induction of Non-classical Epithelial-mesenchymal TransitionSong-Ming Ding, Ai-Li Lu, Jian-Fang Lu, et al.Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|March 14, 2007
[Investigation of intestinal bacterial translocation in 78 patients with cirrhosis after liver transplantation]Zhong-Wen Wu, Kai-Jin Xu, Lan-Juan Li, et al.Pageof 44